|
Aug 1
|
FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales
|
|
Aug 1
|
Does CorMedix (CRMD) Have the Potential to Rally 65.64% as Wall Street Analysts Expect?
|
|
Jul 31
|
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises
|
|
Jul 31
|
UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y
|
|
Jul 30
|
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales
|
|
Jul 29
|
Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
|
|
Jul 24
|
CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock?
|
|
Jul 14
|
Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive?
|
|
Jun 30
|
Circle initiated, Disney upgraded: Wall Street's top analyst calls
|
|
Jun 30
|
Company News for Jun 30, 2025
|
|
Jun 27
|
S&P 500 and Nasdaq Climb to Record Highs on China Trade Optimism
|
|
Jun 27
|
Upgrade: Analysts Just Made A Captivating Increase To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts
|
|
Jun 27
|
S&P 500 and Nasdaq 100 Post Record Highs on Hopes of Trade Deals
|
|
Jun 27
|
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
|
|
Jun 26
|
CorMedix Inc. Announces Proposed Public Offering of Common Stock
|
|
Jun 24
|
CorMedix announces customer implementation
|
|
Jun 24
|
CorMedix Inc. (CRMD): A Bull Case Theory
|
|
Jun 24
|
Strength Seen in CorMedix (CRMD): Can Its 21.7% Jump Turn into More Strength?
|
|
Jun 24
|
US Market's Undiscovered Gems To Explore In June 2025
|
|
May 15
|
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
|